Call them what you will: change makers, thought leaders, people who get stuff done. This is the Science|Business guide to those with the most influence over the size and shape of the EU’s next research programme
At the Euroscience Open Forum conference, a Bulgarian medical start-up demonstrates the potential - and the challenges - of getting health systems to focus on preventing disease, rather than responding when it strikes
‘Radical collaboration’ where multinational companies work together and share data instead of keeping it secret is helping to change the model of the pharmaceutical industry and solve problems more quickly, according to Carlos Moedas, the EU’s commissioner for research, science and innovation, speaking at an IMI 10th anniversary event in Brussels on 27 June.
The UK decision to leave the EU cuts at science’s core ethos of openness. As exit negotiations lurch along, researchers from across Europe are yet to spot a bright side to losing such an important science partner
US officials meeting counterparts in Brussels on next EU research plan, urge more flexibility to make transatlantic research easier - and ask what ‘associate’ partnership would mean
International Science Council unites 180 natural and social sciences organisations ‘to make the voice of science heard by those taking decisions’. One route to increasing influence will be to piggy-back the lobbying might of private sector research
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.